ANAC · Arctos Northstar Acquisition Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - |
| SG&A | $201.9K | $220.5K | $319.6K | - | $1.87M | $224.6K | $432.6K |
| Total Operating Expenses | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - |
| Operating Income | ($231.9K) | ($250.5K) | ($349.6K) | - | ($1.90M) | ($254.6K) | ($452.6K) |
| Interest Expense | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - |
| Net Income | $2.12M | $3.20M | $7.51M | - | $493.5K | $10.67M | ($3.77M) |
| EPS - Basic | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $81.6K | $7.5K | $115.6K | $81.6K | $319.9K | $700.2K | $0 |
| Accounts Receivable | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - |
| Accounts Payable | $106.8K | $49.1K | $43.3K | $40.1K | $240.6K | $56.0K | $388.6K |
| Current Assets | $377.6K | $282.0K | $488.5K | $479.9K | $807.3K | $1.29M | $9.3K |
| Total Assets | $318.55M | $317.02M | $316.78M | $316.75M | $317.07M | $317.54M | $318.90M |
| Current Liabilities | $2.60M | $2.28M | $2.23M | $1.87M | $2.01M | $591.9K | $120.0K |
| Long-term Debt | - | - | - | - | - | - | - |
| Total Liabilities | $14.48M | $15.07M | $18.03M | $25.50M | $25.59M | $26.56M | $120.0K |
| Stockholders' Equity | ($14.00M) | ($14.69M) | ($17.49M) | ($25.00M) | ($24.77M) | $5.00M | $5.00M |
| Retained Earnings | ($14.00M) | ($14.69M) | ($17.50M) | ($25.00M) | ($24.78M) | $5.00M | ($15.7K) |
Cash Flow
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($316.0K) | - | - | - | ($659.1K) |
| Investing Cash Flow | - | - | $0 | - | - | - | ($316.25M) |
| Financing Cash Flow | - | - | $350.0K | - | - | - | $318.10M |
| CapEx | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
Ratios
| Metric | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|
| Profitability | |||||||
| Gross margin | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - |
| Return on assets | 0.7% | 1.0% | 2.4% | - | 0.2% | 3.4% | -1.2% |
| Return on equity | -15.1% | -21.8% | -42.9% | - | -2.0% | 213.5% | -75.5% |
| Return on invested capital | - | - | - | - | - | - | - |
| Liquidity | |||||||
| Current ratio | 0.15 | 0.12 | 0.22 | 0.26 | 0.40 | 2.17 | 0.08 |
| Quick ratio | 0.15 | 0.12 | 0.22 | 0.26 | 0.40 | 2.17 | 0.08 |
| Cash ratio | 0.03 | 0.00 | 0.05 | 0.04 | 0.16 | 1.18 | 0.00 |
| Leverage | |||||||
| Debt / Equity | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - |
| Equity multiplier | -22.75 | -21.58 | -18.11 | -12.67 | -12.80 | 63.51 | 63.78 |
| Liabilities / Assets | 0.05 | 0.05 | 0.06 | 0.08 | 0.08 | 0.08 | 0.00 |
| Efficiency | |||||||
| Asset turnover | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - |
| Valuation | |||||||
| P / E | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - |
| Growth | |||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 87.8% | 1.6% | 22.8% | - | - | - | - |
| Net income growth (YoY) | 328.9% | -70.0% | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - |
| Book value growth (YoY) | 43.5% | - | - | - | - | - | - |
Peer comparison
Same SIC group: Blank Checks
Comparing ARCTOS NORTHSTAR ACQUISITION CORP. against the 5 most active filers in the same SIC group.